A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer-Reference-Cited by-同舟云学术

A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer

Published:2011-06-07 Issue:2 Volume:19 Page:152-158
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:Journal of Hepato-Biliary-Pancreatic Sciences

Author:

Shinchi Hiroyuki¹,Maemura Kosei²,Mataki Yuko²,Kurahara Hiroshi²,Sakoda Masahiko²,Ueno Shinichi²,Hiraki Yoshiyuki³,Nakajo Masayuki³,Natsugoe Shoji²,Takao Sonshin⁴

Affiliation:

1. School of Health Sciences; Kagoshima University Faculty of Medicine; 8-35-1 Sakuragaoka Kagoshima 890-8506 Japan

2. Department of Surgical Oncology and Digestive Surgery; Kagoshima University; Kagoshima Japan

3. Department of Radiology; Kagoshima University; Kagoshima Japan

4. Frontier Science Research Center; Kagoshima University; Kagoshima Japan

Publisher

Wiley

Subject

Hepatology,Surgery

Link

http://www.springerlink.com/index/pdf/10.1007/s00534-011-0400-y

Reference29 articles.

1. The effect of adjuvant and neoadjuvant chemo(radio)therapy on survival in 1679 resected pancreatic carcinoma cases in Japan: report of the national survey in the 34th annual meeting of Japanese Society of Pancreatic Surgery;Sata;J Hepatobiliary Pancreat Surg.,2009

2. Adjuvant treatments for resectable pancreatic cancer;Ueno;J Hepatobiliary Pancreat Surg.,2008

3. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads ⊕ 5-fluorouracil), and high dose radiation ⊕ 5-fluorouracil;Gastrointestinal Tumor Study Group;Cancer,1981

4. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone;Gastrointestinal Tumor Study Group;J Natl Cancer Inst.,1988

5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: a randomized trial;Burris;J Clin Oncol.,1997

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of elderly patients with unresectable pancreatic cancer;Japanese Journal of Clinical Oncology;2022-07-04

2. Long-term survival after distal pancreatectomy with celiac axis resection and hepatic artery reconstruction in the setting of locally advanced unresectable pancreatic cancer;Clinical Journal of Gastroenterology;2022-03-29

3. Factors associated with long-term survival in gemcitabine-concurrent proton radiotherapy for non-metastatic locally advanced pancreatic cancer: a single-center retrospective study;Radiation Oncology;2022-02-10

4. Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2–3 studies;Radiotherapy and Oncology;2021-11

5. Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreatic cancer;Pancreatology;2021-09